3118云顶集团官网

请输入关键字
top
400-815-1117
400-815-1117
股票代码:688068
深化亚太布局,共赢发展新机遇|3118云顶集团官网亮相WHX Labs亚洲国际医疗展
2026-07-03

2026年7月8-10日,WHX Labs Bangkok 2026在泰国曼谷诗丽吉王后国家会议中心盛大举行。


3118云顶集团官网携全场景免疫诊断解决方案精彩亮相,全面展示覆盖中心实验室、POCT、结核检测等领域的创新产品,吸引了来自东南亚及全球众多行业专家、经销商和合作伙伴驻足交流,进一步彰显中国IVD品牌的创新实力与国际影响力。



深耕中亚,推进全球化

Part.1


展位信息

名称:WHX Labs Bangkok 2026

时间:2026年7月8-10日

地点:泰国曼谷诗丽吉王后国家会议中心(Queen Sirikit National Convention Center)

展位号:L04


东南亚是3118云顶集团官网全球化战略的重要市场之一,区域医疗需求持续增长,市场潜力巨大。


借助WHX Labs Bangkok 2026这一国际化平台,3118云顶集团官网与来自东南亚、中东、南亚及其他地区的合作伙伴展开深入交流,进一步推动区域市场拓展和本地化合作进程,为深化亚太市场布局奠定坚实基础。



全矩阵产品亮相

Part.3

本次展会,3118云顶集团官网重点展示了多款高度契合东南亚市场需求的免疫诊断产品,全面覆盖各级医疗机构、基层医疗、急诊急救及公共卫生等多元化应用场景。


化学发光产品线重点展出了MQ60系列、C800及C2100系列产品,可满足不同医疗机构对于高通量、精准化检测的需求;


POCT领域重点展示了UPT2800系统,凭借快速、精准、便携的优势,可广泛应用于基层医疗机构、急诊现场及突发公共卫生事件检测;


结核检测核心产品TB-IGRA,可高效应用于结核感染筛查与临床辅助诊断,满足全球结核防控需求;


此外,3118云顶集团官网还展示了胶体金、ELISA等多种常规检测产品,产品种类丰富,可满足不同市场和客户的多样化需求。


未来,3118云顶集团官网将深化海外本地化运营,赋能东南亚医疗发展。


Strengthening Our Presence in Asia-Pacific, Creating New Opportunities for Shared Growth | HOTGEN Showcases Comprehensive IVD Solutions at WHX Labs Bangkok 2026


From July 8–10, 2026, WHX Labs Bangkok 2026 was successfully held at the Queen Sirikit National Convention Center in Bangkok, Thailand.


HOTGEN made a remarkable appearance with its comprehensive immunodiagnostic solutions, showcasing innovative products across central laboratory testing, point-of-care testing (POCT), and tuberculosis diagnostics. The booth attracted extensive attention from industry experts, distributors, and business partners from Southeast Asia and around the world, further demonstrating the innovation capabilities and growing international influence of China's IVD industry.


Comprehensive Product Portfolio on Display


At this year’s exhibition, HOTGEN highlighted a broad range of immunodiagnostic solutions designed to meet the evolving needs of the Southeast Asian market, covering diverse healthcare scenarios including hospitals, primary healthcare institutions, emergency medicine, and public health.


The chemiluminescence immunoassay portfolio featured the MQ60 Series, C800, and C2100 Series, offering flexible solutions to meet the demands of laboratories of different sizes for high-throughput and accurate testing.


In the POCT segment, HOTGEN presented the UPT2800 System, which delivers rapid, accurate, and portable testing, making it well suited for primary healthcare facilities, emergency settings, and public health emergency response.

HOTGEN also showcased its flagship TB-IGRA solution for tuberculosis infection screening and clinical auxiliary diagnosis, supporting global efforts in tuberculosis prevention and control.


In addition, the company exhibited a wide range of routine diagnostic products, including colloidal gold rapid tests and ELISA assays, providing diversified solutions to address the varying needs of customers across different markets.


Expanding in Asia-Pacific, Accelerating Global Growth


Southeast Asia remains one of the key regions in HOTGEN’s global expansion strategy, driven by continuously growing healthcare demand and significant market potential.


Leveraging the international platform of WHX Labs Bangkok 2026, HOTGEN engaged in in-depth discussions with distributors and partners from Southeast Asia, the Middle East, South Asia, and other regions, further advancing regional market development and localized cooperation while laying a solid foundation for strengthening its presence across the Asia-Pacific market.


Exhibition Information

Exhibition: WHX Labs Bangkok 2026

Date: July 8–10, 2026

Venue: Queen Sirikit National Convention Center, Bangkok, Thailand

Booth: L04


Looking ahead, HOTGEN will continue to advance its global strategy by strengthening localized operations worldwide and empowering healthcare with innovative diagnostic technologies, contributing to better health outcomes across the globe.

上一篇:中华医学会肝病学分会第七次肝癌学术会议 | 创新赋能,3118云顶集团官网守护国人肝健康
下一篇:DDA 盛会即将启幕,3118云顶集团官网携全套 IVD 解决方案亮相印度
Baidu
sogou